Targeted ‘radioligand’ improves survival in advanced prostate cancer
Researchers yield new insights into origins of synovial sarcoma
4 June 2021Team researching how effector and killer T cells can be controlled to destroy cancer cells that resist treatment
4 June 2021Targeted ‘radioligand’ improves survival in advanced prostate cancer
Cancer researchers say they have established a new, life-extending treatment option for men with prostate cancer that has spread and become resistant to hormone therapy. The injected treatment combines a targeting compound with a radioactive isotope to irradiate and kill cancer cells.
